Endothelial functional activity and circadian blood pressure dynamics in hypertensive patients treated with angiotensin receptor antagonists

Endothelial functional activity and circadian blood pressure dynamics in hypertensive patients treated with angiotensin receptor antagonists

Aim. To assess the associations between endothelial functional activity and circadian blood pressure profile (CBPP) in hypertensive patients (Stage I-II arterial hypertension, uncontrolled in ambulatory settings) who were administered candesartan and losartan. Material and methods. The study include...

Full description

Bibliographic Details
Main Authors:	N. G. Poteshkina, G. B. Selivanova, T. Zh. Zhalsaraev
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2011-10-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	arterial hypertension angiotensin receptor antagonists circadian blood pressure profile nitric oxide endothelial function
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1932

Similar Items

AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM ANTAGONIST COMBINATION IN PHARMACOTHERAPY OF ARTERIAL HYPERTENSION
by: L. L. Kirichenko, et al.
Published: (2014-02-01)

Dynamics of endothelial dysfunction, nephropathic and dyslipidemic disorders in patients with insufficient glycemic compensation of type 2 diabetes mellitus during 1 year of application of angiotensin II receptor antagonists for hypertension correction
by: Pertseva N.O.
Published: (2014-11-01)

Efficacy of a fixed-dose combination of perindopril and amlodipine in the treatment of hypertensive patients. A clinical case
by: N G Poteshkina, et al.
Published: (2014-12-01)

PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
by: S. A. Boytsov, et al.
Published: (2016-01-01)

Angiotensin receptor blockers & endothelial dysfunction: Possible correlation & therapeutic implications
by: Miroslav Radenkovic, et al.
Published: (2016-01-01)

Mechanisms of endothelial dysfunction in obesity-associated hypertension
by: N.S. Lobato, et al.
Published: (2012-05-01)

Mechanisms of endothelial dysfunction in obesity-associated hypertension
by: N.S. Lobato, et al.
Published: (2012-05-01)

Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
by: Si-Hyuck Kang, et al.
Published: (2021-06-01)

Thrombin Inhibition Prevents Endothelial Dysfunction and Reverses 20-HETE Overproduction without Affecting Blood Pressure in Angiotensin II-Induced Hypertension in Mice
by: Agnieszka Kij, et al.
Published: (2021-08-01)

Effects of renin-angiotensin system blockers on the risk and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with hypertension
by: Jinwoo Lee, et al.
Published: (2021-03-01)

Ultrastructural changes of platelet granules in patients with type 2 diabetes mellitus and hypertension in applying of angiotensin II receptor antagonists
by: Pertseva N.O.
Published: (2016-06-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND PROTEINURIA
by: Tanja Kök, et al.
Published: (2002-03-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: Shuichi Ichikawa, et al.
Published: (2011-06-01)

Association of urinary 90 kDa angiotensin- converting enzyme with family history of hypertension and endothelial function in normotensive individuals
by: A.M.S. Teixeira, et al.
Published: (2008-05-01)

Modern approaches to the treatment and long-term management of arterial hypertension in clinical practice. Pharmacological and clinical characteristics of angiotensin II receptor blockers: focus on azilsartan medoxomil. Part I
by: M. G Bubnova
Published: (2015-06-01)

Dynamics of renin-angiotensin-aldosteron system and lipid profile in hypertensive hypothyrosis patients during the process of thyroid function compensation
by: P. Kh. Dzhanashiya, et al.
Published: (2004-12-01)

Epilepsy Seizures in Spontaneously Hypertensive Rats After Acoustic Stimulation: Role of Renin–Angiotensin System
by: Christiane Becari, et al.
Published: (2020-12-01)

Increased Endogenous Activity of the Renin-Angiotensin System Reduces Infarct Size in the Rats with Early Angiotensin II-dependent Hypertension which Survive the Acute Ischemia/Reperfusion Injury
by: Zuzana Husková, et al.
Published: (2021-05-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
by: M. L. Maksimov, et al.
Published: (2010-04-01)

Effect of Scurrula atropurpurea on nitric oxide, endothelial damage, and endothelial progenitor cells of DOCA-salt hypertensive rats
by: Nour Athiroh, et al.
Published: (2014-08-01)

Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension
by: Attila Juhasz, et al.
Published: (2018-02-01)

Use of Renin-Angiotensin-Aldosterone System Inhibitors and Severe COVID-19 Outcomes in Patients with Hypertension: A Nationwide Cohort Study
by: Jae Hyun Bae, et al.
Published: (2021-05-01)

EFFECT OF ANGIOTENSIN RECEPTOR BLOCKADE ON ENDOTHELIAL FUNCTION: FOCUS ON OLMESARTAN MEDOXOMIL
by: C. Ferrario
Published: (2010-12-01)

Activation of Yes-Associated Protein/PDZ-Binding Motif Pathway Contributes to Endothelial Dysfunction and Vascular Inflammation in AngiotensinII Hypertension
by: Qian Xu, et al.
Published: (2021-09-01)

Left ventricular hypertrophy: prognostic value, pathogenesis, possible remodeling: focusing on angiotensin receptor antagonists
by: M. D. Smirnova, et al.
Published: (2007-12-01)

Vasoactive mediators of endothelial dysfunction in children and teenagers with hypertension
by: D. I. Sadykova, et al.
Published: (2016-03-01)

Clinical pharmacology of the combination of ACE inhibitors and calcium antagonists: benefits of the perindopril arginine and amlodipine combination
by: M. V. Leonova
Published: (1970-01-01)

Protective Effects of Short-Chain Fatty Acids on Endothelial Dysfunction Induced by Angiotensin II
by: Iñaki Robles-Vera, et al.
Published: (2020-04-01)

Renin-angiotensin and kallikrein-kinin systems in diabetic renal damage
by: Igić Rajko
Published: (2019-01-01)

Relationship between the bioavailability and molecular properties of angiotensin II receptor antagonists
by: Trbojević Jovana B., et al.
Published: (2016-01-01)

The endothelial dysfunction in portal hypertension : role of the oxidative stress and angiotensin system
by: Rashid, Sherzad Khorsheed
Published: (2014)

ARTERIAL HYPERTENSION AND CIRCADIAN BLOOD PRESSURE PROFILE IN CLIMACTERIC WOMEN
by: V. V. Anikin, et al.
Published: (2011-12-01)

Debatable points of using angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in patients with COVID-19
by: O. M. Drapkina, et al.
Published: (2020-07-01)

FIVE-YEAR DYNAMICS OF CIRCADIAN BLOOD PRESSURE PROFILE IN FAR NORTH WORKERS WITH ARTERIAL HYPERTENSION
by: I. L. Zapesochnaya, et al.
Published: (2013-12-01)

GENDER SPECIFICS OF HEART REMODELLING AND CIRCADIAN BLOOD PRESSURE PROFILE IN PATIENTS WITH ARTERIAL HYPERTENSION
by: K. A. Abramova, et al.
Published: (2009-04-01)

Differential effects of Rho-kinase inhibitor and angiotensin II type-1 receptor antagonist on the vascular function in hypertensive rats induced by chronic l-NAME treatment
by: Bainian Chen, et al.
Published: (2012-10-01)

EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

Endothelial Vasodilator Angiotensin Receptors are Changing in Mice with Ageing
by: Majid Malekzadeh Shafaroudi, et al.
Published: (2014-02-01)

Calcium antagonist lercanidipine in hypertension
by: G. A Baryshnikova, et al.
Published: (2014-03-01)

Telmisartan (micardis) - an antagonist of angiotensin II receptors of type 1: one more antihypertensivedrug or something greater?
by: I E Chazora
Published: (2003-06-01)